Observational studyFrontiers in immunology2022

Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.

Tamara Davidovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.